Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Glassman

Showing results (171-180 of 229) with videos related to

Pageof 23
Sort By:
Ophthalmology|May 14, 2020
Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)Adam R Glassman, John A Wells, Kristin Josic, et al.
American Journal of Ophthalmology|January 24, 2016
Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular EdemaSusan B Bressler, Adam R Glassman, Talat Almukhtar, et al.
Retina (Philadelphia, Pa.)|October 1, 2019
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY: Pooled Analysis of Five DRCR Retina Network Randomized Clinical TrialsNeil M Bressler, Wesley T Beaulieu, Susan B Bressler, et al.
Science (New York, N.Y.)|July 27, 2023
Deploying synthetic coevolution and machine learning to engineer protein-protein interactionsAerin Yang, Kevin M Jude, Ben Lai, et al.
Cell|February 19, 2021
Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cellsCaleb R Glassman, Yamuna Kalyani Mathiharan, Kevin M Jude, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 24, 2000
Assisted venous drainage presents the risk of undetected air microembolismA Lapietra, E A Grossi, B B Pua, et al.
Ophthalmology|April 5, 2011
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaMichael J Elman, Neil M Bressler, Haijing Qin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2023
Structure of the Wnt-Frizzled-LRP6 initiation complex reveals the basis for coreceptor discriminationNaotaka Tsutsumi, Sunhee Hwang, Deepa Waghray, et al.
JAMA Ophthalmology|January 10, 2016
Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision ImpairmentSusan B Bressler, Allison R Ayala, Neil M Bressler, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 11, 2009
Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings, Alexander J Brucker, Haijing Qin, et al.
Pageof 23

Showing results (171-180 of 229) with videos related to

Sort By:
Pageof 23
Ophthalmology|May 14, 2020
Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)Adam R Glassman, John A Wells, Kristin Josic, et al.
American Journal of Ophthalmology|January 24, 2016
Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular EdemaSusan B Bressler, Adam R Glassman, Talat Almukhtar, et al.
Retina (Philadelphia, Pa.)|October 1, 2019
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY: Pooled Analysis of Five DRCR Retina Network Randomized Clinical TrialsNeil M Bressler, Wesley T Beaulieu, Susan B Bressler, et al.
Science (New York, N.Y.)|July 27, 2023
Deploying synthetic coevolution and machine learning to engineer protein-protein interactionsAerin Yang, Kevin M Jude, Ben Lai, et al.
Cell|February 19, 2021
Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cellsCaleb R Glassman, Yamuna Kalyani Mathiharan, Kevin M Jude, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 24, 2000
Assisted venous drainage presents the risk of undetected air microembolismA Lapietra, E A Grossi, B B Pua, et al.
Ophthalmology|April 5, 2011
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaMichael J Elman, Neil M Bressler, Haijing Qin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2023
Structure of the Wnt-Frizzled-LRP6 initiation complex reveals the basis for coreceptor discriminationNaotaka Tsutsumi, Sunhee Hwang, Deepa Waghray, et al.
JAMA Ophthalmology|January 10, 2016
Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision ImpairmentSusan B Bressler, Allison R Ayala, Neil M Bressler, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 11, 2009
Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings, Alexander J Brucker, Haijing Qin, et al.
Pageof 23